Injectable
Primarsh 100
100 mg/mL
Primarsh 100 is a methenolone enanthate injectable formulation with an extended ester-release profile. It is sometimes described as comparatively less androgenic, but that does not make it risk-free.
Product Summary
- Product
- Primarsh 100
- Strength
- 100 mg/mL
- Dosage Form
- Injectable
Product Information
Professional injectable product profile.
Product overview: Primarsh 100 contains methenolone enanthate at 100 mg per 1 mL in an oil-based injectable solution. The enanthate ester gives the formulation an extended-release profile compared with shorter ester presentations.
Background and context: The source notes that methenolone is often described in non-medical circles as comparatively less androgenic. That reputation is context only; it should not be read as a claim that the product is safe, side-effect free, or suitable for non-medical use.
Important considerations: Relevant concerns include endocrine suppression, lipid changes, fertility effects, hepatic considerations, and virilisation. The verified carrier system consists of pharmaceutical-grade carrier oil, benzyl benzoate, benzyl alcohol, and Miglyol 840. Catalogue language therefore remains cautious rather than presenting comparative androgenicity as a safety conclusion.
| Product name | Primarsh 100 |
|---|---|
| Strength | 100 mg/mL |
| Active ingredient or blend | Methenolone Enanthate |
| Composition per 1 mL | Methenolone Enanthate 100 mg Oil-based injectable solution |
| Dosage form | Oil-based injectable solution |
| Carrier oil | Pharmaceutical-grade carrier oil; benzyl benzoate; benzyl alcohol; Miglyol 840 |
| Pharmaceutical grade | Pharmaceutical grade carrier system stated in the source |
Inquiry
Request product information for Primarsh 100.
For product enquiries, portfolio discussion, or category coordination, email info@3xpharma.com.